These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5272100)

  • 1. Studies in the design and analysis of dental experiments. 13. Balanced incomplete block design.
    Varma AA; Chilton NW; Kutscher AH
    J Dent Res; 1970; 49(5):1166-71. PubMed ID: 5272100
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissolution duration times of a modified long-lasting lozenge formulation in patients with oral lesions.
    Kutscher AH; Zegarelli EV; Metzger J; Ruiz L; Burns A; Ellegood C
    J Oral Med; 1969 Apr; 24(2):51-2. PubMed ID: 5257797
    [No Abstract]   [Full Text] [Related]  

  • 3. New long-lasting lozenge protectant vehicle for oral mucosal disease.
    Kutscher AH; Zegarelli EV; Ruiz L; Rosell A; Mehrhof A
    N Y State J Med; 1969 Mar; 69(5):687-9. PubMed ID: 5252482
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-lasting lozenges CU 701-1: dissolution duration times in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz LM; McAdams W; Baker N; Robinson G
    Ann Dent; 1968 Dec; 27(4):149-50. PubMed ID: 4886473
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-lasting lozenges CU 701-1: dissolution duration time at home in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz L; Miya C; Forester J
    Q Natl Dent Assoc; 1969 Apr; 27(3):76-7. PubMed ID: 5254949
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-lasting lozenges: dissolution studies with CU 701-1 in patients with oral lesions and in volunteer (normal) subjects.
    Kutscher AH; Kanig JL; Zegarelli EV; Ruiz L
    Mil Med; 1968 Jun; 133(6):471-3. PubMed ID: 4988426
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled-release therapeutic systems: technology applicable to the treatment of oral disease.
    Mirth DB
    Adv Dent Res; 1987 Oct; 1(1):109-18. PubMed ID: 3326612
    [No Abstract]   [Full Text] [Related]  

  • 8. [1st communication on the treatment of burning of the oral mucosa with a synthetic orally applicable depot estrogen].
    Wagner S; Wagner IV
    Dtsch Stomatol; 1970 Nov; 20(11):827-32. PubMed ID: 5274507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Has the pharmaceutical industry forgotten about the oral cavity?].
    Muster D; Ben Slama L
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):72-4. PubMed ID: 16738510
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-lasting lozenge: dissolution duration time in the clinic in patients with oral mucosal lesions.
    Kutscher AH; Zegarelli EV; Ruiz LM; Miller B; Bonfield C
    J Conn State Dent Assoc; 1969 Apr; 43(2):113. PubMed ID: 4976518
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-lasting lozenges with triamcinolone acetonide. Treatment of erosive lichen planus of oral mucosa.
    Zegarelli EV; Kutscher AH; Mehrhof A
    N Y State J Med; 1969 Sep; 69(18):2463-4. PubMed ID: 5257612
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of balanced incomplete block designs in comparative bioavailability trails.
    Westlake WJ
    Biometrics; 1974 Jun; 30(2):319-27. PubMed ID: 4833141
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies in the design and analysis of dental experiments. 14. Replicate latin squares.
    Varma AA; Chilton NW; Kutscher AH
    J Dent Res; 1973; 52(1):23-5. PubMed ID: 4509501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of acute and chronic pain in the maxillo-facial area by means of a long-acting analgesic].
    Neupel HG
    ZWR; 1970 Jun; 79(11):482-4. PubMed ID: 5267848
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action and indications of Sepsis preparations in dentistry].
    Reinecke KP
    Dtsch Stomatol; 1970 Apr; 20(4):266-72. PubMed ID: 5268234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha level distortions with repeated testing of follow-up dental data.
    Cohen ME
    J Dent Res; 1984 Oct; 63(10):1214-6. PubMed ID: 6592203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antibiotics in dental practice.
    Tarsitano JJ
    Dent Clin North Am; 1970 Oct; 14(4):697-710. PubMed ID: 5272455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzymes in dental therapy. Mechanism of action].
    Vieillefosse R; Roussin E
    Rev Fr Odontostomatol; 1968 Jan; 15(1):91-6. PubMed ID: 5243835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prospects for using immobilized enzymes in dentistry].
    DanilevskiÄ­ NF; Khomenko LA; Sidel'nikova LF
    Stomatologiia (Mosk); 1983; 62(3):32-4. PubMed ID: 6193615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.